TSX.V VHI January 2021 - Investor Presentation - Squarespace

Page created by Troy Mcguire
 
CONTINUE READING
TSX.V VHI January 2021 - Investor Presentation - Squarespace
Investor Presentation

     TSX.V VHI

   January 2021
TSX.V VHI January 2021 - Investor Presentation - Squarespace
Reader’s Advisory
This corporate presentation dated January 2021(the “Presentation”) has been prepared by management of Vitalhub Corp. (the “Corporation”), and is based on public information and the Corporation’s confidential information. This Presentation is for information purposes only and is being made
available on a confidential basis solely to enable the prospective “accredited” and other qualified investors authorized by the Corporation to evaluate the securities of the Corporation (the “Securities”). This Presentation does not constitute an offer to sell to any person, or a general offer to the public
of, or the general solicitation from the public of offers to subscribe or purchase, any of the Securities. Any unauthorized use of this Presentation is strictly prohibited. Distribution or copying of this Presentation, in whole or in part in any medium, to any person other than the prospective investor is
prohibited without the prior written consent of the Corporation. The information contained in these slides, the Presentation made to you verbally and any other information provided to you (in writing or otherwise) in connection with the Corporation and its business (the “Presentation Materials”) is
subject to updating, completion, revision, verification and amendment without notice which may result in material changes. The Presentation Materials are not intended to provide financial, tax, legal or accounting advice and do not purport to contain all the information that a prospective investor
may require. Each prospective investor should perform and rely on its own investigation and analysis of the Corporation and the terms of any offering of the Securities, including the merits and risks involved, and are advised to seek their own professional advice on the legal, financial and taxation
consequences of making an investment in the Corporation. The Securities are highly speculative.

No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the Presentation Materials, and any representation to the contrary is an offence. Neither the Corporation nor any agent of the Corporation makes any representation or warranty, express or
implied, and assumes no responsibility for the accuracy or completeness of the information contained in the Presentation Materials or any other oral or written communication transmitted to prospective investors, and nothing contained in this summary is, or shall be relied upon as, a promise or
representation by the Corporation or any agent of the Corporation as to the past or future performance of the Corporation. The Corporation does not undertake to provide any additional further information or to enter into negotiations regarding the investment opportunity to which these
Presentation Materials relate. The Corporation retains the right, at any time, to terminate any discussions or negotiations with prospective investors. In the event of such termination the Corporation will not be under any obligation to disclose the reasons for such termination nor will they have any
liability to any recipient hereof for any costs whatsoever incurred in the consideration of the information contained in these Presentation Materials.

This presentation contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or
variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements contained in this Presentation may include, but are not limited to statements with respect to the successful
execution of the Corporation's business strategy (including its business model. M&A strategy and mission), the use and benefits of its products and services, the Corporation’s favourable position in the market on a go-forward basis, demographic and market size/trends, forecasts of revenue and
financial projections/growth potential/opportunities, the completion of proposed acquisitions of target companies, the use of proceeds from the sale of the Corporation’s Securities, competitive analysis, proposed synergies, projected milestones, go-forward management of the Corporation, and
other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance, expected regulatory filings, review and approval dates, construction and start-up timelines and schedules, and statements related to the continued overall advancement of the
Corporation’s projects. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of Vitalhub’s current and potential customers, foreign currency exchange rates,
as well as general economic conditions, which may cause the actual results, performance or achievements of Vitalhub to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely
to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this presentation.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward looking
statements contained in this presentation are made as of the date hereof or the dates specifically referenced in this presentation, where applicable. Except as required by law, the Corporation undertakes no obligation to update publicly or to revise any forward looking statements that are contained
or incorporated in this presentation. All forward looking statements contained in this presentation are expressly qualified by this cautionary statement. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this presentation.

                                             TSX.V VHI                                                                                                                                                                                                                                                               3
TSX.V VHI January 2021 - Investor Presentation - Squarespace
Company Overview
Software Consolidator Focused on Health & Human Services Digital Solutions

                           Large, Addressable and Fragmented Market

           Sizable Organic Growth                             Synergistic M&A Growth
             TSX.V VHI                                                                 4
TSX.V VHI January 2021 - Investor Presentation - Squarespace
Company Overview

The Company                                                              The Strategy
• High organic growth assets coupled with a targeted M&A strategy        • Targeted acquisition of synergistic assets that, taken together, yield a
                                                                           robust and highly-valuable suite of solutions
• Strong financial position with high margins, EBITDA positive and
  growing Annualized Contract Value (“ACV”)                              • Organic growth platform achieved through the growing needs of the
                                                                           sizable and fragmented patient flow and operational visibility market
• Long-term, high quality customer base across the Hospital,
  Community Agency and Mental Health space, with an emphasis on          • Solutions targeting patient flow inefficiencies resulting in cost-savings
  end-to-end patient flow and operational visibility solutions           • Realizing revenue and cost synergies through M&A acquisition strategy
• SaaS-based, high-margin products sold organically across the digital   • Offshore R&D strategy that cuts costs, increases margins and produces
  health marketplace                                                       synergized product offerings
• Management team and Board of Directors with proven success             • International sales spanning six countries, including the U.S., U.K.,
                                                                           Canada, Australia, Qatar and Latvia

                       TSX.V VHI                                                                                                                       5
TSX.V VHI January 2021 - Investor Presentation - Squarespace
The VitalHub Leadership Team – Management
Dan Matlow President & CEO                                   Vijit Coomara EVP of Development
• 30 years of experience in technology with a focus on       • 30 years of experience in Development and Technology
  Health IT
                                                             • Previously CTO & Co-Founder at B Sharp
• Previously CEO & Founder at Medworxx
• Track record of building and growing enterprise software
  companies
                                                             Robert Lazar EVP of Professional Services & Customer Care
                                                             • 28 years of experience
Brian Goffenberg, CPA, CA Executive VP & CFO
                                                             • Previously CEO & Co-Founder at B Sharp
• 30 years of experience, multiple CFO roles
• Previously CFO at Medworxx
                                                             Niels Tofting EVP of Business Development & Marketing
                                                             • 20 years of software experience
                                                             • Previously VP Sales at Logibec

                   TSX.V VHI                                                                                             6
TSX.V VHI January 2021 - Investor Presentation - Squarespace
The VitalHub Leadership Team – Board of Directors
Dan Matlow                                                     Roger Dent
• President & CEO Vitalhub Corp.                               • Chief Executive and Director of
                                                                 Quinsam Capital Corporation

Francis Shen                                                   • Former Portfolio Manager with Matrix Fund Management and
                                                                 Director of Research for CIBC World Markets
• President of Shen Capital Corporation
• Former Chairman, Co-Chief Executive Officer and founder of   Barry Tissenbaum
  Aastra Technologies Ltd.
                                                               • Retired fmr. Senior Partner with Ernst & Young
                                                               • Currently serves on the Noranda Income Fund Board, and is
Chris Schnarr                                                    Chairman of the Audit Committee
• Managing Director of Lorian Group Inc.
                                                               Steve Garrington
• Director, Chair of the Audit Committee, and member of the
                                                               • Former Director of 3 public companies listed on Canadian,
  Governance and Compensation Committees of Canopy
  Growth Corporation and Intrinsic 4D Inc.                       Australian, and UK exchanges
                                                               • Former Executive Vice President InterSystems Inc.

                    TSX.V VHI                                                                                                7
TSX.V VHI January 2021 - Investor Presentation - Squarespace
Canada
Market Size and Opportunity                                                           Europe
             3 million beds                                                           Middle East
             across target
             regions                                                                  Australia

                               $1.5 billion marketplace
                                   Significant opportunity for organic growth

             VitalHub’s patient flow platforms currently
                                                                 $500 per bed per year for a suite of
             support an install base representing                VitalHub patient flow & operational
             50,000 beds across 15 countries                     visibility modules

       TSX.V VHI                                                                                        8
Timeline: EHR, Case Management (FY16 – FY18)

                    2016                                 H2 2017 – H1 2018                                  H2 2018

  • VitalHub Corp. purchased by key           • Acquired B-Sharp Technologies, 24-          Acquisition of Roxy Software Inc. (closed
    former members of the Medworxx              person offshore development team, 5         September 2018)
    management team in May of 2016.             products focusing on mental health;         • Revenue of $279,275 recurring
  • Completion of the closing of qualifying     generating ~CAD $1.4M in recurring            revenue of $271,170
    transaction and                             revenue
                                                                                            Nova Scotia Provincial Deal (closed
    public offering                           • Acquired H.I. Next Inc., large US install   December 2018)
                                                base, web-based EHR platform built for
                                                                                            • $20 million in revenue over 10 years
                                                health care providers, tailored to
                                                Behavioral and Mental Health,               • Grow to $2.5 million in annual
                                                Community, Primary Care, etc.                 recurring revenue
                                              • Acquired Clarity Health, Ontario Mental
                                                Health-based assessments, $200k in
                                                recurring revenue

                TSX.V VHI                                                                                                               9
Timeline: Patient Flow & Operational Visibility (FY19)
Strategic Entry into
Patient Flow &
Operational
Visibility Market:                                          Q1 2019                                                           Q4 2019

•   Acquisition of
                                   Acquisition of The Oak Group Inc. (closed March 2019):           Acquisition of Oculys Health Informatics Inc.:
    synergistic assets to
                                   • trailing 12-month revenue of $847,000, with $751,000           (closed November 2019)
    develop end-to-end
    patient flow and                 recurring                                                      • trailing 12-month revenue of $2,066,540, with $1,559,177
                                   • sales across four countries U.K., Canada, Australia, and         recurring
    operational
    visibility                       Qatar                                                          • 18 hospital customers located across Ontario and
                                                                                                      Manitoba
•   Well established               The Oak Group is a software and service provider, offering its
    head-start in area             propriety ‘Making Care Appropriate for Patients’ (“MCAP”)        Oculys provides real-time and predictive operational
    of rapid                       System. MCAP is a robust patient flow solution comprising        management systems designed specifically for complex
    transformation and             clinically-based criteria sets combined with a software data-    hospital environments with technology to connect leaders
    need, especially               gathering and reporting systems. It is used to place and         and teams to the pulse of their operations – from the
    post-COVID-19                  identify patients for admission or continued stay at the least   Emergency Department wait times to
                                   intensive and most appropriate level of care.                    Operating Room performance to bed
                                                                                                    utilization and to patient flow bottlenecks.

                       TSX.V VHI                                                                                                                               10
Timeline: Patient Flow & Operational Visibility (FY20)
Expansion of
international
Patient Flow Market
and Synergy with                                               Q3 2020                                                        Q3 2020
existing platform:                   Acquisition of InTouch with health. (closed August 2020):       Acquisition of Transforming Systems Ltd. (Announced
•   Acquisition of                   • trailing 12-month revenue of £3,141,975, with £1,329,198      agreement to acquire August 2020):
    synergistic assets                 recurring                                                     • trailing 12-month revenue of £2,218,192, with £1,880,962
                                     • sales across four countries; UK, Qatar, Australia, Latvia       recurring
•   Strong references,
                                       with a fifth pending; Canada                                  • Their solutions are currently used at 37 regional NHS
    opportunity to
                                                                                                       organizations in the UK. Transforming Systems are a “NHS
    grow in Canada,                  Intouch’s “Intouch Patient Journey Platform,” is currently        National Innovation Accelerator” with two of their current
    continued demand                 utilized in over 53 National Health Service (“NHS”) Trusts in     solutions
    for solutions during             the UK as well and internationally, and processes over 30
    COVID                            million appointments annually, Intouch helps hospitals and      Transforming Systems was established to solve the
                                     private healthcare providers, in the United Kingdom,            challenges associated with how to capture, transform, and
                                     Australia, Latvia, and Qatar, increase their organizational     provide actionable insights from a wide range of health data
                                     efficiency and deliver an improved patient experience by way    to drive behavioural change. Working with their National
                                     of improved communication and information management,           Health Services (“NHS”) partners, they deliver award winning
                                     cost reductions and overall quality improvements. The           patient flow visibility solutions through their “SHREWD
                                     platform is comprised of three (3) product suites: Patient      platform.”
                                     Flow, Clinical hub, and Pre-operative assessments (under the
                         TSX.V VHI                                                                                                                             11
                                     Synopsis Healthcare banner)
Mental Health, Community, and Long-Term Care
                                                                                                                         Strategically consolidating current
                                                     Acquired Q1 2018                                                    Canadian market (which is serviced by
                                                                                                                         small, independent vendors) through:
         TREAT is a full-featured health record and client                 TREAT is focused on client-                   • Acquisitions
         management system that supports community                         centered, outcome-based case                  • Displacement via large
         agencies across Canada and the United States in                   management, as well as                            implementations requiring
         a hosted SaaS-based environment. It is the most                   transparent and robust reporting.                 comprehensive solutions
         widely-used product of its kind in Canada.

                                                                                                                                                 VitalHub is a
             Acquired Q4 2017                                Acquired Q1 2018                                 Acquired Q3 2018
                                                                                                                                                 leader in this
                                                                                                    Roxy provides “Pirouette” - a web-based
B Care is a full-featured electronic health      Clarity offers a web-based interface and data                                                  are, with over
                                                                                                    software solution comprising case
record that supports small regional hospital     entry solution used by leading healthcare          management, assessments, and health         150 customers
deployments with an emphasis on mental           organizations to perform in-patient assessments,   record and reporting tools designed to         currently
health and rehabilitation facilities, offering   streamlining resident assessments and reporting    help manage programs, workload, and         utilizing our 4
functionality that can be used as a primary      for complex continuing and long-term care          data more effectively among smaller            products
hospital patient information system              providers                                          community agencies
                           TSX.V VHI                                                                                                                     12
Patient Flow & Operational Visibility Market
Patient flow:

•   is the movement of patients through a healthcare facility or amongst different facilities
                                                                                                      There is a need for
•   involves the medical care, physical resources, and internal systems needed to get patients from   connectivity across
    the point of admission to the point of discharge while maintaining quality and patient/provider   disparate health care
                                                                                                      silos for patient flow &
    satisfaction.
                                                                                                      operational visibility
Operational Visibility:                                                                               data.
•   is the ability to see, in real time, a view of all your operational resources (enabling load
    balancing across capacity and demand)

    Current covid-19 pandemic has resulted in healthcare paradigm shift necessitating greater insight into real-time
                                            patient flow & operational visibility analytics

                     TSX.V VHI                                                                                                   13
TSX.V VHI   14
Patient Flow & Operational Visibility Solutions
      prEDict (ED Wait Time Clock)                 houseOPS
      Broadcasts ED performance to the             optimizes housekeeping
      community and discharge processes            leveraging the dashOPS module

      dashOPS                                      bedOPS
      Integrates key operational data optimizing   Optimizes bed management through
      the patient journey & utilization            intelligent workflows

      stayTrack                                    famOPS
      Improves communication and discharge         Tracks the patient flow journey for
      processes                                    families

      MCAP
      Clinical decision support & utilization
      management

        TSX.V VHI                                                                        15
Patient Flow & Operational Visibility Solutions
                                              Synopsis IQ
       SHREWD Elective
                                              The complete digital pre-op assessment platform, from
       Whole system visibility of demand,
                                              initial questionnaire to post-operative outcomes
       capacity and ‘waits’ in planned care
                                              Synopsis Home
                                              Enabling patients to complete their pre-op health
       SHREWD Resiliance                      questionnaire outside the hospital.
       Examine whole-system visibility of
       pressure in three seconds              iReceptionist
                                              Connect patients and hospital visitors to your remote
       SHREWD Action                          reception team
       Broadcasts ED performance to the       Wait Time Manager
       community and discharge processes      A digital dashboard that communicates clinic wait times,
                                              problem areas and potential delays.
       SHREWD COVID-19
       Broadcasts ED performance to the       Virtual Clinics
       community and discharge processes      The fully integrated virtual and video consultations
        TSX.V VHI                                                                                     16
M&A Strategy
VitalHub’s strategy is to rapidly increase growth and profitability by combining like software companies focused
in the Healthcare IT area

 Reduce R&D Spend             Consolidate G&A    Cross-Selling Products        Optimize S&M             Sell Organically
  Reduction of R&D            Consolidation of    Upselling VitalHub        Implementation of       Develop and sell new
   costs by moving               finance and       mHealth platform          effective sales and    VitalHub products into
development offshore           administration       into install base       marketing processes     large growth markets
 with a significantly           into a central
    reduced wage               functional area
      structure

                  TSX.V VHI                                                                                                  17
M&A Strategy – Acquisition Targets
                                              Target companies are
       Have identified 400
                                              synergistic with annual                Combination of cash
       companies primarily in
                                              revenues of $1M-$12M,                  and stock using the
       Canada, UK and Australia
                                              profitable with limited                public markets
       that are looking for exits
                                              growth, and have not
                                              adopted a mobile strategy

                                              Target 20%-30% EBITDA
       Reduce costs by 20%                                                           Purchase companies
                                              with cross-selling and
       through synergistic
 20%   reductions and utilization   20%-30%   synergistic cost
                                              reductions including
                                                                          1.0-2.5x
                                                                                     between
                                                                                     1.0x-2.5x revenue
       of cost-effective offshore                                                    multiple
                                              effective offshore
       resources
                                              development work

         TSX.V VHI                                                                                   18
M&A Strategy – What We Look For
Target Companies possess these qualities
• Recurring revenue above 60% of total revenue

• Breakeven or profitable

• Owner operated businesses with limited outside investment

• Large component of expense is on research and development vs. sales and marketing

• Little commercialization or sales and marketing expertise

• Significant customer base with minimal retention issues

• Limited or no expansion beyond geographical boundaries creating a large growth barrier

• Ability to upsell to existing install bases of target companies by bringing their product
 into a mobile environment

                    TSX.V VHI                                                                 19
Revenues – last eight quarters

       TSX.V VHI                 20
Revenues – last eight quarters
 Total Revenue        Term licenses, maintenance and support   Perpetual licenses   Services and other   % Recurring revenues

                 TSX.V VHI                                                                                                      21
Historical Financial Performance
Historical Adjusted EBITDA (C$ MM)

    Adjusted EBITDA           Adjusted EBITDA Margin (%)

                  TSX.V VHI                                22
Historical Annualized Contract Value (“ACV”)
Historical ACV (C$ MM)          ACV            ACV Growth %

        $16.0

        $14.0                                                          $13.6

        $12.0

        $10.0

         $8.0                                                 $7.4

         $6.0
                                       $4.5
         $4.0
                                      316.7%

         $2.0
                         $1.1
                                                              65.6%   82.5%
            -            0.0%
                         2017         2018                    2019    Q3 2020

                TSX.V VHI                                                       23
Last eight quarters ACV and quarter on quarter growth in ACV
                                                       Vitalhub adds $1M new
                                                       annualized contract
                                                       value in Q4
     ACV                                               2021-01-19 10:10 ET -
                                                       News Release

     Quarter on quarter Growth in ACV (%)

             TSX.V VHI                                                         24
Capitalization & Shareholder Summary
Capitalization (C$ MM)                                                              Shareholder Summary
 Share Price                                                     C$       $3.110

 Basic Shares Outstanding                                       MM           36.1
  Plus: Stock Options Outstanding                               MM            2.2
  Plus: Warrants Outstanding                                    MM            1.3
 F.D. Shares Outstanding                                        MM           39.6

 Basic Market Capitalization                               C$ MM          $112.4
 F.D. Market Capitalization                                C$ MM          $123.1

 Cash Balance                                               C$ MM          $27.0
 Loans Payable                                              C$ MM           $0.2

 Net Cash Position                                         C$ MM           $26.8

                                                            Stock
 Stock Options & Warrants                                  Options Warrants

 Amount Outstanding                                 MM          2.2          1.3
 Weighted Avg. Exercise Price                       C$        $1.92        $3.57

 Potential Proceeds                            C$ MM            $4.2         $4.5

Source: Public filings and internal company information as at January 18, 2021

                                   TSX.V VHI                                                              25
Closed a $15.3M bought deal offering on March 17, 2020
• Vitalhub Corp. has closed its previously announced bought-deal offering pursuant to a press release dated Feb. 21, 2020. A total of
  8,506,300 common shares of Vitalhub were sold at a price of $1.80 per common share for total gross proceeds of approximately
  $15.3-million. The offering was conducted by a syndicate of underwriters led by Cormark Securities Inc. and including Beacon
  Securities Ltd. and Canaccord Genuity Corp. The offering included 1,006,300 common shares issued pursuant to the exercise of a
  portion of the overallotment option granted to the underwriters. The common shares were qualified for distribution by a short-
  form prospectus in the provinces of Ontario, British Columbia and Alberta.

• In connection with the offering, the company paid the underwriters a cash commission of $839,363.40 and issued to the
  underwriters 228,750 broker warrants. Each broker warrant entitles the underwriters to purchase a common share at an exercise
  price of $2.10 until March 17, 2022.

• The net proceeds of the offering will be used for growth initiatives, working capital and general corporate purposes. The company's
  growth initiative is focused on the acquisition of thirdparty enterprises in the health care industry which provide synergistic
  opportunities for the company.

                   TSX.V VHI                                                                                                        26
Closed a $17M bought deal offering on November 17, 2020
• Vitalhub Corp. has closed its previously announced bought deal offering pursuant to a press release dated Oct.
  26, 2020. A total of 5,860,775 common shares of Vitalhub were sold at a price of $2.90 per common share for
  total gross proceeds of approximately $17-million. The offering was conducted by a syndicate of underwriters
  led by Cormark Securities Inc. and including Canaccord Genuity Corp., Beacon Securities Ltd., Eight Capital and
  Paradigm Capital Inc. The offering included 688,275 common shares issued pursuant to the exercise of a
  portion of the overallotment option granted to the underwriters. The common shares were qualified for
  distribution by a short-form prospectus in the provinces of Ontario, British Columbia and Alberta.

• The net proceeds of the offering will be used for growth initiatives, working capital and general corporate
  purposes. The company's growth initiative is focused on the acquisition of third party enterprises in the health
  care industry, which provide synergistic opportunities for the company.

                TSX.V VHI                                                                                       27
Comparables

      TSX.V VHI   28
Nova Scotia Announcement (Closed Dec. 2018)
The Nova Scotia Department of Community Services has signed a five-year agreement
with VitalHub, with options to extend for a total of five additional years, to license
VitalHub’s TREAT client management software to support the Department of
Community Services (DCS) transformation following the issuance of a Request For
Proposal (RFP) for a digitally enabled Collaborative Case Management Solution.

•   Complete transformation of DCS’s entire software package

•   2,000 Internal employee users and 20,000 clients that will use the system

•   Material transaction resulting in a committed contract value of $20 million in revenue over
    10 years

•   Will grow to $2.5 million in annual recurring revenue

                    TSX.V VHI                                                                     29
Offshore Development Hub: VitalHub Innovations Lab
Forty+ member offshore development team located in Sri Lanka
                                                                            Colombo, Sri Lanka

Strong Healthcare domain expertise, with experience in building state-of-
the-art healthcare applications to support digital health products across
hospitals and community care settings

Characteristics

• In operation since 2007

• Team of 44 developers
                                                                            44 Member Offshore
• Average tenure of 4 years                                                  Development Team

                  TSX.V VHI                                                                      30
Investment Highlights - Summary
                             Large Addressable Market across Targeted Digital Health Solutions
                         1   • Focused on the Mental Health, Long term Care, and Community Agency sectors
                             • Patient Flow and Operational Visibility solutions portfolio launched with acquisition of
                               Oak Group (Q1 2019
                             History of Successful M&A Execution
                         2   • 8 acquisitions completed with ~400 potential targets currently identified
                             • Target cost reduction of 20% and EBITDA increase of 20% to 30%

                             Strong ACV Growth with High-Quality Customers
VitalHub Corp. is        3   • M&A targets have recurring revenue >60% of total revenue
                             • Recent contract win – Nova Scotia has licensed VitalHub’s client management software
being traded on the
                             Seasoned Management Team with Extensive Healthcare IT Experience
TSX Venture Exchange     4   • Combined 200+ years of experience in healthcare and technology
under VHI                    • History of founding and operating Healthcare IT companies (e.g. Medworxx, B Sharp)

                             Low-Cost Development Hub
                         5   • Operates offshore R&D in Sri Lanka with a significantly reduced cost structure
                             • 40 member off-shore development team

             TSX.V VHI                                                                                                    31
Appendix B: Additional Information
Medworxx History
• International Healthcare IT company that was publicly traded on the TSX.V
• Unique Patient Flow solutions originating from use at Canadian hospitals
• Solutions are used by over 70% of hospitals across Canada
• Grew internationally to over $8 million in revenue across five countries
• Share price grew from 5 cents in 2008 to 60 cents in 2015 (CAGR 30% beds under license)
• Sold to Aptean, a subsidiary of Vista Equity Partners, in October 2015 for a valuation
  of $20 million

                                       Canada         United States          Australia      France   U.K

                 TSX.V VHI                                                                                 33
New Strategic Investors
VitalHub Corp. completed a non-brokered private placement of units with the former
founders and management team of Aastra Technologies Ltd.

• The offering was completed at a price 16 cents per unit for gross proceeds of $3.3 million, and a total of 20,625,000 units issued (at
  the time – a consolidation of share capital on a 10 for 1 basis occurred in January 2020).
• The investors comprise:
     • Francis Shen, founder, former chairman and co-chief executive officer of Aastra;
     • Tony Shen, former president, chief operating officer and co-CEO of Aastra;
     • Allan Brett, former chief financial officer at Aastra and current CFO at Descartes Systems Group Inc.;
     • John Tobia, general counsel and current vice-president of merger and acquisition at Aastra and general counsel at Sangoma
       Technologies Corp.

                   TSX.V VHI                                                                                                          34
Investor Presentation

                     TSX.V VHI

Dan Matlow, President & CEO dan.matlow@vitalhub.com

Brian Goffenberg, CFO brian.Goffenberg@vitalhub.com
You can also read